7NQ9

C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 2-benzyl-N-cyclopropyl-6-(1-methyl-1H-1,2,3-triazol-4-yl)isonicotinamide

This is a non-PDB format compatible entry.

Summary for 7NQ9

• Entry DOI: 10.2210/pdb7nq9/pdb
• Related: 7NQ5 7NQ7 7NQ8
• Descriptor: Bromodomain-containing protein 2, 6-benzyl-N4-((1r,3r)-3-hydroxycyclobutyl)-N2-methylpyridine-2,4-dicarboxamide, 1,2-ETHANEDIOL, ... (4 entities in total)
• Functional Keywords: inhibitor, histone, epigenetic reader, bromodomain, brd2, bromodomain containing protein 2, antagonist, nuclear protein
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 1
• Total formula weight: 14082.19

Authors

Chung, C.W. (deposition date: 2021-03-01, release date: 2021-03-24, Last modification date: 2024-06-19)

• Primary citation: Aylott, H.E.,Atkinson, S.J.,Bamborough, P.,Bassil, A.,Chung, C.W.,Gordon, L.,Grandi, P.,Gray, J.R.J.,Harrison, L.A.,Hayhow, T.G.,Messenger, C.,Mitchell, D.,Phillipou, A.,Preston, A.,Prinjha, R.K.,Rianjongdee, F.,Rioja, I.,Seal, J.T.,Wall, I.D.,Watson, R.J.,Woolven, J.M.,Demont, E.H.; Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors.; J.Med.Chem., 64:3249-3281, 2021; PubMed: 33662213; DOI: 10.1021/acs.jmedchem.0c02156

Experimental method

X-RAY DIFFRACTION (1.602 Å)